Cas 1382997-15-0,1-(3-bromo-5-chloro-4-fluoro-2-hydroxyphenyl)ethan-1-one

1382997-15-0

Post Buying Request

Basic information

Product Name: 1-(3-bromo-5-chloro-4-fluoro-2-hydroxyphenyl)ethan-1-one
Synonyms: 1-(3-bromo-5-chloro-4-fluoro-2-hydroxyphenyl)ethan-1-one
CAS NO:1382997-15-0
Molecular Formula:
Molecular Weight: 267.482
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(3-bromo-5-chloro-4-fluoro-2-hydroxyphenyl)ethan-1-one(CAS DataBase Reference)
NIST Chemistry Reference: 1-(3-bromo-5-chloro-4-fluoro-2-hydroxyphenyl)ethan-1-one(1382997-15-0)
EPA Substance Registry System: 1-(3-bromo-5-chloro-4-fluoro-2-hydroxyphenyl)ethan-1-one(1382997-15-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1382997-15-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1382997-15-0 Suppliers

Recommended suppliers

1382997-15-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1382997-15-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,2,9,9 and 7 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1382997-15:
(9*1)+(8*3)+(7*8)+(6*2)+(5*9)+(4*9)+(3*7)+(2*1)+(1*5)=210
210 % 10 = 0
So 1382997-15-0 is a valid CAS Registry Number.

1382997-15-0Upstream product

1382997-15-0Downstream Products

1382997-32-1 1-(3-bromo-5-chloro-4-fluoro-2-methoxyphenyl)ethanone

1382997-15-0Relevant academic research and scientific papers

METHODS OF CANCER TREATMENT USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH PI3 KINASE DELTA INHIBITORS

-

Paragraph 0133-0134, (2021/05/29)

Provided are methods of treating cancer with non-competitive, agonist anti-OX40 antibodies and antigen-binding fragments thereof that bind to human OX40 (ACT35, CD134, or TNFRSF4), in combination with a PI3K (phosphatidylinositol-4, 5-bisphosphate 3-kinas

IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS

-

Paragraph 0111; 0112; 0178; 0179, (2019/04/10)

Disclosed is a compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating PI3Kδ related disorders or diseases by using the c

IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORS

-

Paragraph 0441; 0442; 0622; 0623, (2018/06/30)

USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS

-

Paragraph 0294, (2014/09/16)

The present application provides methods of treating PI3Kδ related disorders using compounds of Formula I: or pharmaceutically acceptable salts thereof.

HETEROCYCLYLAMINES AS PI3K INHIBITORS

-

Paragraph 0839, (2013/03/26)

The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

PYRIMIDINE-4,6-DIAMINE DERIVATIVES AS PI3K INHIBITORS

-

Page/Page column 48, (2012/10/18)

The present invention provides pyrimidine-4,6-diamine derivatives of Formula (I): wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activit

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1382997-15-0